Literature DB >> 9343212

A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

M P Wentz1, B E Moore, M W Cloyd, S M Berget, L A Donehower.   

Abstract

We have isolated a naturally arising human immunodeficiency type 1 (HIV-1) mutant containing a point mutation within the env gene. The point mutation resulted in complete loss of balanced splicing, with dominant production of aberrant mRNAs. The aberrant RNAs arose via activation of normally cryptic splice sites flanking the mutation within the env terminal exon to create exon 6D, which was subsequently incorporated in aberrant env, tat, rev, and nef mRNAs. Aberrant multiply spliced messages contributed to reduced virus replication as a result of a reduction in wild-type Rev protein. The point mutation within exon 6D activated exon 6D inclusion when the exon and its flanking splice sites were transferred to a heterologous minigene. Introduction of the point mutation into an otherwise wild-type HIV-1 proviral clone resulted in virus that was severely inhibited for replication in T cells and displayed elevated usage of exon 6D. Exon 6D contains a bipartite element similar to that seen in tat exon 3 of HIV-1, consisting of a potential exon splicing silencer (ESS) juxtaposed to a purine-rich sequence similar to known exon splicing enhancers. In the absence of a flanking 5' splice site, the point mutation within the exon 6D ESS-like element strongly activated env splicing, suggesting that the putative ESS plays a natural role in limiting the level of env splicing. We propose, therefore, that exon silencers may be a common element in the HIV-1 genome used to create balanced splicing of multiple products from a single precursor RNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343212      PMCID: PMC192318     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  Regulation of HIV-1 gene expression.

Authors:  B R Cullen
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 2.  Regulation of human immunodeficiency virus replication.

Authors:  B R Cullen
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA.

Authors:  X D Fu; R A Katz; A M Skalka; T Maniatis
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

4.  A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.

Authors:  D M Benko; S Schwartz; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.

Authors:  M Robert-Guroff; M Popovic; S Gartner; P Markham; R C Gallo; M S Reitz
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

7.  Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.

Authors:  B K Felber; C M Drysdale; G N Pavlakis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

8.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

Authors:  S Schwartz; B K Felber; D M Benko; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing.

Authors:  T A Cooper; C P Ordahl
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

View more
  30 in total

1.  SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.

Authors:  Massimo Caputi; Alan M Zahler
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 3.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

4.  A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well.

Authors:  Gerrit M Daubner; Antoine Cléry; Sandrine Jayne; James Stevenin; Frédéric H-T Allain
Journal:  EMBO J       Date:  2011-10-14       Impact factor: 11.598

5.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

6.  The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity.

Authors:  Joseph A Jablonski; Emanuele Buratti; Cristiana Stuani; Massimo Caputi
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

7.  hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.

Authors:  F Del Gatto-Konczak; M Olive; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  Characterizing HIV-1 Splicing by Using Next-Generation Sequencing.

Authors:  Ann Emery; Shuntai Zhou; Elizabeth Pollom; Ronald Swanstrom
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

9.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.